Litigation Details for Humana Inc. v. Gilead Sciences, Inc. (N.D. Cal. 2021)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2021-12-12
Court	District Court, N.D. California	Date Terminated
Cause		Assigned To	Edward Milton Chen
Jury Demand		Referred To
Patents	6,043,230; 6,639,071; 6,642,245; 6,703,396; 6,939,964
Link to Docket	External link to docket

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

The biologic drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2021-12-13	1	Complaint	23 patent”), and 6,043,230 (“the ’230 patent”) — all derived from the same patent application… 22 Three of the patents — U.S. Patents Nos. 5,922,695 (“the ’695 patent”), 5,977,089 (“the ’089…relevant patent or patents expired, or would have challenged 2 those patents and entered…or, for any later-issued patent, within thirty days of issuance of the patent. 21 U.S.C. …relevance of the manufacturer’s patents. Therefore, in listing patents in the 25	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document